Tapivir HBV Tablets: Product Description, Uses, Benefits, Strengths and Side Effects

Tapivir HBV Tablets are a product name associated with antiviral treatment information for hepatitis B. Available medicine references identify Tapivir 100 mg Tablets as containing lamivudine 100 mg as the active ingredient. Before publishing this description for Tapivir HBV, confirm the exact product name, composition and strength against the manufacturer's approved product label.

Lamivudine is an antiviral medicine that helps control the replication of hepatitis B virus (HBV). It may be prescribed for eligible patients with chronic hepatitis B under medical supervision. It does not eliminate the virus in every patient, and ongoing monitoring is important during treatment.

For patients and healthcare professionals in Singapore, product selection should be based on an appropriate medical assessment, verified product information and applicable Health Sciences Authority (HSA) requirements.

Active Ingredient and Strength

Active ingredient: Lamivudine (reported for Tapivir 100 mg Tablets; verify the specific HBV product label).

Reported strength: 100 mg per tablet.

Dosage form: Oral tablet.

Therapeutic category: Antiviral medicine.

Primary treatment context: Chronic hepatitis B virus infection, where clinically appropriate.

The precise strength and approved indication of a particular Tapivir HBV product must be confirmed before ordering or dispensing. Do not assume that products with similar brand names have identical compositions.

Uses and Potential Benefits of Tapivir HBV Tablets

1. Helps control hepatitis B virus replication

Lamivudine interferes with viral replication, helping reduce the amount of hepatitis B virus in the body. Treatment response varies between patients and should be evaluated through appropriate laboratory tests.

2. Supports management of chronic hepatitis B

When prescribed for an appropriate indication, antiviral treatment can help manage chronic HBV infection. A healthcare professional determines whether lamivudine is suitable based on the patient's medical history, liver condition and previous antiviral treatment.

3. Helps monitor disease progression

Reducing viral activity may support the overall management of hepatitis B. Regular assessments, including liver function tests and HBV-related blood tests, help healthcare professionals evaluate treatment effectiveness and ongoing liver health.

4. Convenient oral dosage form

Tablets provide an oral administration option. Patients should follow their prescribed schedule and the instructions supplied with their specific medicine.

Important: Lamivudine resistance can develop during hepatitis B treatment. It is not appropriate to describe Tapivir as a guaranteed cure or as superior to alternative antivirals without reliable clinical evidence.

Possible Side Effects

Like other antiviral medicines, lamivudine may cause side effects. Possible effects include:

Headache

Nausea or vomiting

Diarrhoea

Abdominal discomfort

Fatigue

Seek prompt medical attention for severe or unusual symptoms, including significant muscle pain or weakness, breathing difficulties, or signs of serious liver problems. Rare but serious complications can occur with some antiviral treatments.

Patients with HIV and hepatitis B co-infection require specialist assessment because lamivudine alone is not an appropriate complete HIV treatment regimen. Never start, change or discontinue treatment without medical advice. Stopping hepatitis B therapy can cause a serious flare-up of the infection.

Frequently Asked Questions (FAQs)

1. What is the active ingredient in Tapivir HBV Tablets?

Available references identify Tapivir 100 mg Tablets as containing lamivudine 100 mg. Verify the composition of the specific Tapivir HBV product using its original packaging and manufacturer documentation.

2. What are Tapivir HBV Tablets used for?

Lamivudine is an antiviral medicine used in the management of chronic hepatitis B in appropriate patients. The indication for the exact product must be confirmed.

3. What strength is available?

Tapivir 100 mg Tablets are listed in medicine references. Availability of a separately branded Tapivir HBV formulation and its strength should be independently verified.

4. Can Tapivir HBV cure hepatitis B?

Treatment can suppress viral replication, but lamivudine does not reliably cure chronic hepatitis B. Continued monitoring and individualised medical care are essential.

5. Is Tapivir HBV available in Singapore?

Confirm current product registration and supply status through Singapore's HSA and a licensed healthcare provider or pharmacy. Online availability does not itself establish regulatory approval.

6. Can I stop taking Tapivir when I feel better?

No. Do not stop antiviral treatment without consulting your doctor, as hepatitis B can worsen after treatment is discontinued.

Important Medical and Regulatory Information

This content is for general educational purposes and is not a substitute for professional medical advice.